Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The helminth glycoprotein omega-1 improves metabolic homeostasis in obese mice through type 2 immunity-independent inhibition of food intake.
van der Zande HJP, Gonzalez MA, de Ruiter K, Wilbers RHP, García-Tardón N, van Huizen M, van Noort K, Pelgrom LR, Lambooij JM, Zawistowska-Deniziak A, Otto F, Ozir-Fazalalikhan A, van Willigen D, Welling M, Poles J, van Leeuwen F, Hokke CH, Schots A, Yazdanbakhsh M, Loke P, Guigas B. van der Zande HJP, et al. Among authors: van huizen m. FASEB J. 2021 Feb;35(2):e21331. doi: 10.1096/fj.202001973R. FASEB J. 2021. PMID: 33476078 Free PMC article.
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site.
van Vliet VJE, Huynh N, Palà J, Patel A, Singer A, Slater C, Chung J, van Huizen M, Teyra J, Miersch S, Luu GK, Ye W, Sharma N, Ganaie SS, Russell R, Chen C, Maynard M, Amarasinghe GK, Mark BL, Kikkert M, Sidhu SS. van Vliet VJE, et al. Among authors: van huizen m. PLoS Pathog. 2022 Dec 22;18(12):e1011065. doi: 10.1371/journal.ppat.1011065. eCollection 2022 Dec. PLoS Pathog. 2022. PMID: 36548304 Free PMC article.
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.
van Huizen M, Bloeme-Ter Horst JR, de Gruyter HLM, Geurink PP, van der Heden van Noort GJ, Knaap RCM, Nelemans T, Ogando NS, Leijs AA, Urakova N, Mark BL, Snijder EJ, Myeni SK, Kikkert M. van Huizen M, et al. PLoS Pathog. 2024 Mar 25;20(3):e1012100. doi: 10.1371/journal.ppat.1012100. eCollection 2024 Mar. PLoS Pathog. 2024. PMID: 38527094 Free PMC article.
Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial.
Landman AJEMC, de Boer MA, Visser L, Nijman TAJ, Hemels MAC, Naaktgeboren CN, van der Weide MC, Mol BW, van Laar JOEH, Papatsonis DNM, Bekker MN, van Drongelen J, van Pampus MG, Sueters M, van der Ham DP, Sikkema JM, Zwart JJ, Huisjes AJM, van Huizen ME, Kleiverda G, Boon J, Franssen MTM, Hermes W, Visser H, de Groot CJM, Oudijk MA. Landman AJEMC, et al. Among authors: van huizen me. PLoS Med. 2022 Feb 1;19(2):e1003892. doi: 10.1371/journal.pmed.1003892. eCollection 2022 Feb. PLoS Med. 2022. PMID: 35104279 Free PMC article. Clinical Trial.
An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial.
Freeman L, Middeldorp J, van den Akker E, Oudijk M, Bax C, van Huizen M, Radder C, Fong B, Bloemenkamp K, Dahan A, Struys M, Mol BW, van Lith J, van den Akker-van Marle E. Freeman L, et al. Among authors: van huizen m. PLoS One. 2018 Oct 11;13(10):e0205220. doi: 10.1371/journal.pone.0205220. eCollection 2018. PLoS One. 2018. PMID: 30307986 Free PMC article. Clinical Trial.
An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp K, Scheepers H, Bremer HA, Rijnders R, van Loon AJ, Perquin D, Sporken J, Papatsonis D, van Huizen ME, Vredevoogd CB, Brons J, Kaplan M, van Kaam AH, Groen H, Porath M, van den Berg PP, Mol B, Franssen M, Langenveld J; HYPITAT-II Study Group. van Baaren GJ, et al. Among authors: van huizen me. BJOG. 2017 Feb;124(3):453-461. doi: 10.1111/1471-0528.13957. Epub 2016 Mar 10. BJOG. 2017. PMID: 26969198 Clinical Trial.
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Among authors: van huizen me. Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Lancet. 2015. PMID: 25817374 Clinical Trial.
Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E₂ gel (PROBAAT trial).
van Baaren GJ, Jozwiak M, Opmeer BC, Oude Rengerink K, Benthem M, Dijksterhuis MG, van Huizen ME, van der Salm PC, Schuitemaker NW, Papatsonis DN, Perquin DA, Porath M, van der Post JA, Rijnders RJ, Scheepers HC, Spaanderman M, van Pampus MG, de Leeuw JW, Mol BW, Bloemenkamp KW. van Baaren GJ, et al. Among authors: van huizen me. BJOG. 2013 Jul;120(8):987-95. doi: 10.1111/1471-0528.12221. Epub 2013 Mar 26. BJOG. 2013. PMID: 23530729 Clinical Trial.
22 results